# Rectal Misoprostol as a Hemostatic Agent During Abdominal Myomectomy

> **NCT03064568** · PHASE4 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 18 (actual)

## Conditions studied

- Myomectomy; Surgical Blood Loss

## Interventions

- **DRUG:** Misoprostol 200Mcg Tab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03064568
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-14
- **Primary completion:** 2024-06-18
- **Final completion:** 2024-06-18
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03064568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03064568, "Rectal Misoprostol as a Hemostatic Agent During Abdominal Myomectomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03064568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*